<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04520503</url>
  </required_header>
  <id_info>
    <org_study_id>pre-induction EEG</org_study_id>
    <nct_id>NCT04520503</nct_id>
  </id_info>
  <brief_title>Relationship Between Pre-induction Electroencephalogram Pattern of Adult Patients and Their Sensitivity to Propofol</brief_title>
  <official_title>Relationship Between Pre-induction Electroencephalogram Pattern of Adult Patients and Their Sensitivity to Propofol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The induction dose of propofol is generally determined based on patients' characteristics,&#xD;
      underlying disease, general condition, and also by clinician's experiences. However, It is&#xD;
      difficult to anticipate and objectively calculate an adequate dose of propofol for every&#xD;
      patient considering the variability of an individual's response to propofol. If there is a&#xD;
      specific pattern in EEG prior to induction of anesthesia that can provide information about&#xD;
      the patient's susceptibility to propofol, every induction may be performed far more smoothly&#xD;
      with a precisely optimized dose of propofol for each patient. The study is to find a&#xD;
      relationship between the pre-induction EEG pattern of adult patients and their sensitivity to&#xD;
      propofol.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Absolute and Relative power in distinct frequency (% δ: 1-4 Hz, % θ: 5-8 Hz, % α: 9-12 Hz, % β: 13-25 Hz)</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>Relative power in distinct frequency (% δ: 1-4 Hz, % θ: 5-8 Hz, % α: 9-12 Hz, % β: 13-25 Hz)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Processed EEG index (PSI; patient state index)</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>Processed EEG index (PSI; patient state index)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean frequency and 95% spectral edge frequency (Hz)</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>Mean frequency and 95% spectral edge frequency (Hz)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Burst suppression ratio (%)</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>Burst suppression ratio (%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The effect-site concentrations of propofol at loss of consciousness (μg/ml)</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>The effect-site concentrations of propofol at loss of consciousness (μg/ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The dose of propofol required for loss of consciousness (mg)</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>The dose of propofol required for loss of consciousness (mg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amount of propofol used (mg)</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>Total amount of propofol used (mg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to loss of consciousness (second)</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>Time to loss of consciousness (second) after the start of induction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital sign - blood pressure</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>Check blood pressure (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital sign - heart rate</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>Check heart rate (beats per minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Administration of vasopressors (ephedrine, phenylephrine, epinephrine, etc)</measure>
    <time_frame>During the induction of anesthesia (up to 15 min)</time_frame>
    <description>Administration of vasopressors (ephedrine (mg), phenylephrine (mcg), epinephrine (mcg), etc)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Propofol Overdose of Undetermined Intent</condition>
  <arm_group>
    <arm_group_label>Pre EEG group</arm_group_label>
    <description>This cohort includes all participants in this study. EEG sensor will be attached to the patient's forehead before induction of anesthesia. Patterns of EEG and data will be obtained</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>The dose of propofol required for loss of consciousness and the total induction dose of propofol will be recorded for every patients.</description>
    <arm_group_label>Pre EEG group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG monitoring</intervention_name>
    <description>The processed EEG spectrogram and indices, such as patient status index, 95% spectral edge frequency, and suppression ratio, will be obtained from Sedline monitoring device. The raw pre-induction EEG will be extracted from Sedline at the end of induction and it will be analyzed by an external software to calculate the mean frequency, frequency band power and its distribution.</description>
    <arm_group_label>Pre EEG group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients, who are aged between 20 and 89 years old, undergoing general anesthesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients undergoing general anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing cardiac or brain surgery&#xD;
&#xD;
          -  Patients with neurological deficit or impaired communication (Glasgow Coma Scale &lt; 15)&#xD;
&#xD;
          -  Unstable vital sign (cardiogenic, hemorrhagic, septic shock)&#xD;
&#xD;
          -  Patients with eclampsia&#xD;
&#xD;
          -  Patients who administered preoperative anxiolytics&#xD;
&#xD;
          -  Patients who do not require intubation&#xD;
&#xD;
          -  Patients who are considered unsuitable for the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Tae Kim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin-Tae Kim, PhD</last_name>
    <phone>82-2-2072-3664</phone>
    <email>jintae73@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JINTAE KIM, M.D / Ph.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>August 5, 2020</study_first_submitted>
  <study_first_submitted_qc>August 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2020</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Professor (full)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Drug Overdose</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

